Gene · 10890
Papers1,621
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,621
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical Genetic Targeting of the LRRK2 GTPase Domain. | bioRxiv | 2026 | 42818643 | PubTator, text mining | PubMed |
| LRRK2: Molecular Mechanisms in Parkinson's Disease. | Int J Mol Sci | 2026 | 42737506 | PubTator, text mining | PubMed |
| Protocol to quantify LRRK2-mediated Rab10 phosphorylation using high-content imaging. | STAR Protoc | 2026 | 42696457 | PubTator, text mining | PubMed |
| DHA Targets RAB1B to Mediate the Driving Force Transmission of Copper Ion Vesicular Endocytosis Under Copper Overload for Promoting Cuproptosis and Ferroptosis in Hepatic Stellate Cells. | Int J Biol Sci | 2026 | 42694667 | PubTator, text mining | PubMed |
| Rab10 coordinates SADS-CoV non-lytic egress through the ERGIC-TGN-lysosome trafficking pathway. | PLoS Pathog | 2026 | 42678995 | PubTator, text mining | PubMed |
| Subtype-specific secretion of extracellular vesicles by LRRK2 and Rab GTPases under lysosomal stress. | iScience | 2026 | 42630748 | PubTator, text mining | PubMed |
| Glial control of extracellular α-synuclein propagation in LRRK2 Parkinson's disease. | Adv Immunol | 2026 | 42629126 | PubTator, text mining | PubMed |
| Rab10 Promotes Atlastin-Mediated Endoplasmic Reticulum Membrane Fusion. | FASEB J | 2026 | 42561046 | PubTator, text mining | PubMed |
| Large-scale functional annotation establishes a reference framework for human LRRK2 variants. | medRxiv | 2026 | 42396337 | PubTator, text mining | PubMed |
| Protective Effects of Taurine Against Zearalenone-Induced Quality Impairment During Porcine Oocyte Maturation. | FASEB J | 2026 | 42333697 | PubTator, text mining | PubMed |
| RASD2 Drives Renal Clear Cell Carcinoma Progression via RAF1 (Ser338) Phosphorylation. | Cancer Sci | 2026 | 42226617 | PubTator, text mining | PubMed |
| A Multistage Virtual Screening Strategy Integrating Molecular Similarity, Deep Learning Scoring, and Molecular Docking toward the Discovery of Novel LRRK2 Inhibitors. | J Chem Inf Model | 2026 | 42187161 | PubTator, text mining | PubMed |
| Parkinson's disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity. | bioRxiv | 2026 | 42094571 | PubTator, text mining | PubMed |
| The downregulation of RAB10 by miR-574-5p alleviates the inflammatory response in neonatal respiratory distress syndrome. | Exp Lung Res | 2026 | 42001430 | PubTator, text mining | PubMed |
| Japanese encephalitis virus orchestrates GLUT4-mediated glucose metabolism to potentiate viral replication via insulin receptor signaling. | PLoS Pathog | 2026 | 41996449 | PubTator, text mining | PubMed |
| Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy. | Mov Disord | 2026 | 41987507 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and glucocerebrosidase activity. | Elife | 2026 | 41925724 | PubTator, text mining | PubMed |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, Pathways, and Therapeutic Implications. | Neurol Int | 2026 | 41893052 | PubTator, text mining | PubMed |
| LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial. | Nat Med | 2026 | 41876647 | PubTator, text mining | PubMed |
| Mechanism of action and clinical application of autophagy in multiple sclerosis (Review). | Int J Mol Med | 2026 | 41860040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10890/papers